Evidence
Same model and position · retrieved passages supplied · first output
The rapid growth of biological data, together with the scarcity of experimentally determined labels, has made large-scale unlabeled datasets a defining feature of modern bioinformatics. Foundation models are particularly adept at handling such data, which has allowed them to achieve notable results across a range of downstream biological tasks.
Passages supplied to the Evidence version
Card 1 · Progress and Opportunities of Foundation Models in Bioinformatics
Bioinformatics has witnessed a paradigm shift with the increasing integration of artificial intelligence (AI), particularly through the adoption of foundation models (FMs). These AI techniques have rapidly advanced, addressing historical challenges in bioinformatics such as the scarcity of annotated…
Read full passage excerpt
Bioinformatics has witnessed a paradigm shift with the increasing integration of artificial intelligence (AI), particularly through the adoption of foundation models (FMs). These AI techniques have rapidly advanced, addressing historical challenges in bioinformatics such as the scarcity of annotated data and the presence of data noise. FMs are particularly adept at handling large-scale, unlabeled data, a common scenario in biological contexts due to the time-consuming and costly nature of experimentally determining labeled data. This characteristic has allowed FMs to excel and achieve notable results in various downstream validation tasks, demonstrating their ability to represent diverse biological entities effectively. Undoubtedly, FMs have ushered in a new era in computational biology, especially in the realm of deep learning. The primary goal of this survey is to conduct a systematic investigation and summary of FMs in bioinformatics, tracing their evolution, current research status …
Card 2 · RadioPathomics: Multimodal Learning in Non-Small Cell Lung Cancer for Adaptive Radiotherapy
Current practice in cancer treatment collects multimodal data, such as radiology images, histopathology slides, genomics and clinical data. The importance of these data sources taken individually has fostered the recent rise of radiomics and pathomics, i.e., the extraction of quantitative features f…
Read full passage excerpt
Current practice in cancer treatment collects multimodal data, such as radiology images, histopathology slides, genomics and clinical data. The importance of these data sources taken individually has fostered the recent rise of radiomics and pathomics, i.e., the extraction of quantitative features from radiology and histopathology images collected to predict clinical outcomes or guide clinical decisions using artificial intelligence algorithms. Nevertheless, how to combine them into a single multimodal framework is still an open issue. In this work, we develop a multimodal late fusion approach that combines hand-crafted features computed from radiomics, pathomics and clinical data to predict radiotherapy treatment outcomes for non-small-cell lung cancer patients. Within this context, we investigate eight different late fusion rules and two patient-wise aggregation rules leveraging the richness of information given by CT images, whole-slide scans and clinical data. The experiments in le …
Card 3 · TRONCO: an R package for the inference of cancer progression models from heterogeneous genomic data
MOTIVATION: We introduce TRanslational ONCOlogy (TRONCO), an open-source R package that implements the state-of-the-art algorithms for the inference of cancer progression models from (epi)genomic mutational profiles. TRONCO can be used to extract population-level models describing the trends of accu…
Read full passage excerpt
MOTIVATION: We introduce TRanslational ONCOlogy (TRONCO), an open-source R package that implements the state-of-the-art algorithms for the inference of cancer progression models from (epi)genomic mutational profiles. TRONCO can be used to extract population-level models describing the trends of accumulation of alterations in a cohort of cross-sectional samples, e.g. retrieved from publicly available databases, and individual-level models that reveal the clonal evolutionary history in single cancer patients, when multiple samples, e.g. multiple biopsies or single-cell sequencing data, are available. The resulting models can provide key hints for uncovering the evolutionary trajectories of cancer, especially for precision medicine or personalized therapy. AVAILABILITY AND IMPLEMENTATION: TRONCO is released under the GPL license, is hosted at http://bimib.disco.unimib.it/ (Software section) and archived also at bioconductor.org. CONTACT: [email protected] SUPPLEMENTARY INFORMATION: S …
Model-reported card use
Card 1 · fact
Affected output: The rapid growth of biological data, together with the scarcity of experimentally determined labels, has made large-scale unlabeled datasets a defining feature of modern bioinformatics.
Model explanation: The row supplied the premise that unlabeled data dominate biological contexts because experimental labeling is time-consuming and costly, which grounds the opening sentence of the new paragraph.
Card 1 · terminology
Affected output: Foundation models are particularly adept at handling such data
Model explanation: The row provided the field-native phrasing 'particularly adept at handling' for describing foundation models' relation to unlabeled data.